RVMD
NASDAQ
$180.39
Revolution Medicines Inc (RVMD)
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
This company is also listed under the following ticker: RVMDW.
Website: https://www.revmed.comSector:
Healthcare
Industry:
Biotechnology
Buy
Target: $200.50 (+11.15%)
Market Cap
$37B
EPS 5Y CAGR
+30.12%
FCF 5Y CAGR
+56.22%
Free Cash Flow Yield
-2.90%
Price Chart
Valuation
Market Cap$37B
P/S9035.10
P/B26.21
Profitability
Gross Profit (TTM)-$1.13B
EBITDA-$1.38B
EPS-$7.05
Financial Health
Free Cash Flow Yield-2.90%
Growth & Risk
EPS 5Y CAGR+30.12%
FCF 5Y CAGR+56.22%
Beta (5Y)1.09
Sharpe Ratio2.53